Soyon Hong

Dr. Hong studies neuron-glia-immune interactions regulating synaptic fate in neurodegeneration. Dr. Hong received her PhD in Neuroscience in 2012 from Harvard University, after having trained with Dr Dennis Selkoe, and completed her post-doctoral fellowship at Boston Children’s Hospital and Harvard Medical School in 2018 in the lab of Dr Beth Stevens. While in this latter role, she conducted a study that was among the first to propose microglia as critical players in synaptic pathology in disease. In fall 2018, Dr Hong started her lab at the UK DRI, where the lab employs spatial and single-cell omics as well as functional studies in disease models to profile intercellular neuroimmune/neuroglial interactions and how they may confer region-specific synapse vulnerability in disease. For her works, Dr. Hong was named the 2023 Alzheimer’s Research UK David Hague Early Career Investigator of the Year, and was awarded Chan Zuckerberg Initiative Neurodegeneration Challenge Network Collaborators Grant in 2022.